Exagen Inc.

NASDAQ: XGN · Real-Time Price · USD
9.70
0.35 (3.80%)
At close: Aug 15, 2025, 3:59 PM
9.49
-2.11%
After-hours: Aug 15, 2025, 04:18 PM EDT

Exagen Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
55.64M 52.55M 45.56M 48.3M
Cost of Revenue
22.53M 23.09M 24.21M 20.59M
Gross Profit
33.11M 29.46M 21.35M 27.71M
Operating Income
-13.64M -22.84M -40.55M -24.07M
Interest Income
767K 1.52M 830K 16K
Pretax Income
-15.1M -23.66M -47.67M -26.68M
Net Income
-15.12M -23.69M -47.39M -26.85M
Selling & General & Admin
41.37M 47.43M 52.02M 44.54M
Research & Development
5.38M 4.87M 9.88M 7.24M
Other Expenses
n/a n/a n/a 16K
Operating Expenses
46.75M 52.29M 61.89M 51.78M
Interest Expense
2.23M 2.33M 2.45M 2.63M
Selling & Marketing Expenses
1.4M 1.5M 3M 1.7M
Cost & Expenses
69.28M 75.39M 86.11M 72.37M
Income Tax Expense
12K 33K -282K 175K
Shares Outstanding (Basic)
18.2M 17.68M 17.08M 15.97M
Shares Outstanding (Diluted)
18.2M 17.68M 17.08M 15.97M
EPS (Basic)
-0.83 -1.34 -2.77 -1.68
EPS (Diluted)
-0.83 -1.34 -2.77 -1.68
EBITDA
-11.14M -19.15M -43.11M -23.1M
EBIT
-12.87M -21.32M -45.22M -24.05M
Depreciation & Amortization
1.72M 2.17M 2.11M 948K